Back to search results
NCT07510581

Evaluatation of a Microcurrent + Cold Therapy Device

Enrolling by Invitation
NAAges 25–65InterventionalTreatment
Therabody, Inc.
~100 participants
Updated 2026-04-03 on ClinicalTrials.gov
What's tested:Acute Microcurrent TreatmentAcute Microcurrent + cold therapy8-week Chronic Use of Microcurrent + Cold Therapy

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Expert grading
Measured over 8-weeks
+4 more outcomes measured

Conditions

Skin Health

Explore related trials

Skin Health

Where it's being run

1 sites across 1 states
New Jersey1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Subject is female or male (approximately 85% female and 15% male)
Subject is between the ages of 25-65 (no more than 25% 55-65 per group)
Individuals with fine lines/wrinkles, lack of firmness, dullness, and uneven skin tone with a grade of at least 3 on a 10-point scale.
Individuals with sensitive skin.
Individuals who are able to cooperate with the Principal Investigator and study personnel throughout the duration of the study and are willing to comply with all study procedures, methods, evaluations, and study product use.
Individuals who are able to read and sign and informed consent.
Individuals who are able to receive emails on their cellular phones and are capable of completing electronic Informed Consents and/or Questionnaires on their device.
Individuals willing to be photographed and sign a model release.

Exclusion

Individuals who have had Botox in the last 3 months prior to Baseline.
Individuals who have had Filler (Including Lip Filler) in the last 6 months prior to Baseline.
Individuals with a history of atopic eczema, psoriasis, or onychomycosis.
Individuals who have used a topical or system medication within 14 days prior to Baseline.
Individuals who are on anti-acne drugs, topical and/or oral retinoids.
Individuals currently on GLP1 medications or other weight loss regimens.
Individuals who have used a beauty device of any kind in a clinical testing facility in the past 5 months prior to Baseline.
Individuals who have used self-tanners and/or tanning beds within 14 days prior to Baseline.
Individuals currently participating in other clinical studies that are testing a face product and/or device.
Individuals with uncontrolled medical condition(s), including dermatological problems, which could put them at risk in the opinion of the Principal Investigator or compromise the study outcome and/or chronic or serious diseases and conditions which would prevent participation in this clinical study such as cancer, AIDS, insulin-dependent diabetes, renal impairment, mental illness, and/or drug/alcohol addiction.
Individuals with a history of melanoma, or a treated skin cancer within the last 5 years.
Individuals who are pregnant, lactating, or planning to become pregnant. -Individuals who become pregnant during the study must inform the Principal Investigator immediately.
Individuals who are unreliable or unlikely to be available for the duration of the study.
Individuals with a history of allergic reactions, skin sensitization and/or known allergies to cosmetic and personal care products/ingredients.
Individuals who are immunocompromised.
Individuals who are employees of VCS, other testing firms/laboratories, consumer products, and/or raw goods manufacturers/suppliers.
Individuals who are unable to communicate or cooperate with the Principal Investigator/study personnel due to language problems, poor mental development, or impaired cerebral function.
Individuals who started hormones within the last three months preceding the commencement of the study.
Individuals who are using oral contraception for less than three months before study commencement or who have changed their contraceptive method within the three months before the Baseline visit or planning to modify their contraception treatment within the duration of the study.
Individuals who have regular salon and/or dermatological procedures that can interfere with study results (Microdermabrasion, Fillers, Facial Peels, etc.) and are not willing to stop throughout the study.
Individuals with facial tattoos and facial piercings (that can't be removed).
Individuals with tattooed/permanent make up (i.e., eyeliner, eyebrows, lip liner, etc.), eyebrow microblading, and/or eyelash extensions.
Individuals who plan to change their hairstyle throughout the course of the study or who wear hair coverings regularly (i.e., wigs, coloring, extensions, etc.).

What this trial measures

  • Expert grading8-weeks

    Expert clinical grading will be used to measure a variety of skin health appearance measures including: fine lines/wrinkles, firmness, elasticity, radiance plumping (lips), contour (cheeks), pore appearance, lift (mid-face and jowls), nasolabial folds, and skin tone evenness. These will be graded on a scale from 0 to 10, with 0 representing a positive outcome (i.e., no wrinkles) and 10 representing a negative outcome (i.e., numerous, deep wrinkles). These will be assessed by an expert grader.

  • Cutometer8 weeks

    The Cutometer MPA 580 measures the viscoelastic properties of the skin using suction and a probe to determine the penetration depth using an optical measuring system. The resistance of the skin to be sucked up by the negative pressure (firmness) and its ability to return to its original position (elasticity) are calculated and displayed as curves. The Cutometer outputs include many parameters of different portions of the measurement curve including R0 (Uf, firmness), R2 (Ua/Uf, gross elasticity), R5 (Ur/Ue, net elasticity), R7 (Ur/Uf, elastic portion) and R9 (R3\[last max amp\]-R0\[Uf\], fatigue). Elasticity will be reported using the R5 (Ur/Ue) parameter, as the skin becomes more elastic this value will increase. Skin Firmness will be reported using the R0 (Uf) parameter, as the skin becomes firmer this value will decrease. R0 (elasticity) and R5 (firmness) will be the only two parameters provided.

  • VISIA CR Imaging8 weeks

    The VISIA-CR is a clinical facial imaging system used to analyze skin conditions. Images are taken in a variety of lighting conditions (Standard 1, Raked, Cross Polarized, and Primos 3D) to assess wrinkle depth and texture. Images will be taken of the face, utilizing the following angles: 45 degrees right, straight on, and 45 degrees left with the following lighting conditions: Standard 1, Raked, Cross Polarized, and Primos 3D. Analysis is performed by Canfield. The VISIA-CR provides a percentile value compared to others with similar skin (the higher the better); the feature count (the lower the better) and the absolute score (the lower the better).

  • Clinical Photography8 weeks

    Clinical photography involves analysis of high-resolution images taken at different angles (45 degrees right, straight on, 45 degrees left) to compare in a side-by-side format at each time point. Images at each time point will be compared to highlight key changes in skin condition.

  • Participant perceptions of skin health8 weeks

    Participants will complete subjective questionnaires ranking the impact of the treatment on overall skin health measures, including: finelines, facial puffiness, bounce, resiliency, sculpting of jawline, firmness, lift, plumping (lips), texture, comfort, plumpness, facial contour, rejuvenation, skin tone, sagging skin, and liveliness. Participants will also rank enjoyment, convenience, ease of use, and comfort of device usage. All measures will be ranked on a 5-point Likert scale, with 0 indicating strongly disagree and 5 indicating strongly agree.